Markets:

Overview

News

Currencies

International

Treasuries

Merck & Co (NY:MRK)

122.43 +0.57 (+0.47%)

Streaming Delayed Price Updated: 3:23 PM EST, Feb 20, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Merck & Co

< Previous 1 2

...

21 22 23 24 25 26 27 28 29

...

99 100 Next >

Top 3 Health Care Stocks You'll Regret Missing This Month ↗

February 06, 2025

Via Benzinga

Analysts Defend Merck Amid Investor Concerns Over Weak Guidance ↗

February 05, 2025

Merck reported Q4 sales of $15.62 billion, surpassing estimates, with EPS at $1.72. Goldman Sachs remains bullish despite a lower-than-expected 2025 outlook.

Via Benzinga

Uncover the latest developments among S&P500 stocks in today's session. ↗

February 04, 2025

Let's have a look at what is happening on the US markets one hour before the close of the markets on Tuesday. Below you can find the top S&P500 gainers and losers in today's session.

Via Chartmill

Merck (MRK) Q4 2024 Earnings Call Transcript ↗

February 04, 2025

MRK earnings call for the period ending December 31, 2024.

Via The Motley Fool

Topics Earnings

Looking for the most active stocks in the S&P500 index on Tuesday? ↗

February 04, 2025

Looking for the most active S&P500 stocks in today's session? Join us as we dive into the US markets on Tuesday and discover the stocks that are dominating the trading activity and setting the pace for...

Via Chartmill

Why Merck Stock Is Plummeting Today ↗

February 04, 2025

Via The Motley Fool

Market Whales and Their Recent Bets on MRK Options ↗

January 31, 2025

Via Benzinga

A Closer Look at Merck & Co's Options Market Dynamics ↗

January 29, 2025

Via Benzinga

Merck Retail Traders See Buying Opportunity As Stock Dives Toward Worst Day in 17 Years On Weak Guidance ↗

February 04, 2025

Gardasil, its HPV vaccine, posted a 17% decline in sales to $1.55 billion, primarily due to lower demand in China.

Via Stocktwits

Curious about which S&P500 stocks are generating unusual volume on Tuesday? Find out below. ↗

February 04, 2025

Let's take a closer look at the S&P500 stocks with an unusual volume in today's session on Tuesday. Stay informed about the market activity below.

Via Chartmill

Discover which S&P500 stocks are making waves on Tuesday. ↗

February 04, 2025

Get insights into the S&P500 index performance on Tuesday. Explore the top gainers and losers within the S&P500 index in today's session.

Via Chartmill

Why Merck (MRK) Stock Is Falling Today

February 04, 2025

Shares of global pharmaceutical company Merck (NYSE:MRK) fell 11% in the morning session after the company reported mixed fourth-quarter earnings. Its full-year revenue and EPS guidance missed by a...

Via StockStory

Forecasting The Future: 12 Analyst Projections For Merck & Co ↗

January 28, 2025

Via Benzinga

Balancing Dividends and Fundamentals: The Case of NYSE:MRK. ↗

January 28, 2025

Exploring MERCK & CO. INC. (NYSE:MRK)'s dividend characteristics.

Via Chartmill

Why This Beaten-Down Stock Is a Buy in 2025 and Beyond ↗

January 27, 2025

Via The Motley Fool

US Stocks Rise Despite China's Trade Fears, Palantir Defies Gravity, Gold Rallies Further: What's Driving Markets Tuesday? ↗

February 04, 2025

U.S. stocks advanced midday Tuesday, demonstrating resilience despite escalating geopolitical tensions and trade uncertainties between the world’s two largest economies.

Via Benzinga

Gapping S&P500 stocks in Tuesday's session ↗

February 04, 2025

Curious about the market action on Tuesday? Dive into the US markets to explore the gap up and gap down stocks in the S&P500 index during today's session.

Via Chartmill

Get insights into the top movers in the S&P500 index of Tuesday's pre-market session. ↗

February 04, 2025

The US market is yet to commence its session on Tuesday, but let's get a preview of the pre-market session and explore the top S&P500 gainers and losers driving the early market movements.

Via Chartmill

Merck Tops Q4 Earnings And Revenue Estimates ↗

February 04, 2025

Merck came out with quarterly earnings of $1.72 per share.

Via Talk Markets

Topics Stocks / Equities

Merck's Gardasil Vaccine Slowdown In China Bites Again, Stock Falls On Weak 2025 Outlook ↗

February 04, 2025

Merck posted Q4 sales of $15.62 billion, driven by Keytruda's 19% growth. FY25 guidance lags estimates, citing Gardasil shipment pause in China and forex impact.

Via Benzinga

PayPal, Estée Lauder, UBS And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session ↗

February 04, 2025

Via Benzinga

Merck’s (NYSE:MRK) Q4 Sales Top Estimates But Stock Drops

February 04, 2025

Global pharmaceutical company Merck (NYSE:MRK) reported Q4 CY2024 results beating Wall Street’s revenue expectations, with sales up 6.8% year on year to $15.62 billion. On the other hand, the company’s...

Via StockStory

Merck Tops Q4 Forecasts, But Dow Jones Giant Dives On 2025 Guidance ↗

February 04, 2025

Merck topped Wall Street's Q4 expectations Tuesday, but the stock is taking a hit on light guidance.

Via Investor's Business Daily

Topics Stocks

Merck Vs. Pfizer: Which Pharmaceutical Giant Will Prevail In Q4 Earnings? ↗

February 03, 2025

Merck and Pfizer are heading into fourth quarter earnings with different technical setups, leaving investors unsure of which stock will prevail. While Merck shows short-term strength, Pfizer is...

Via Benzinga

The Dogs Of The Dow 2025 ↗

January 31, 2025

The Dogs of the Dow is an investing strategy well-known to retail and institutional investors.

Via Talk Markets

Topics Stocks Stocks / Equities

Is Big Pharma About To Win? Goldman Sachs Weighs In On 340B And Medicaid Shifts ↗

January 31, 2025

Goldman Sachs analyst Salveen Richter highlights potential benefits for biopharma from 340B reforms, while Medicaid cuts could pose risks for companies with significant drug exposure.

Via Benzinga

Earnings Scheduled For February 4, 2025 ↗

February 04, 2025

Via Benzinga

5 Top Stocks to Buy in February 2025 ↗

January 31, 2025

All of them have great upside.

Via The Motley Fool

RFK Jr. And Big Pharma: Health Secretary Hopeful Answers Pointed Questions On Drugs, Insurance, Trump Exec Orders ↗

January 29, 2025

Kennedy seeks to be Secretary of Health and Human Services — a position that would put him in charge of the health of the American people.

Via Benzinga

Topics Government

The RFK Jr. Effect: Biotech Stocks Brace For 'Games' In Senate Hearings ↗

January 29, 2025

The Senate will meet Wednesday to start the confirmation hearing process for Robert F. Kennedy Jr.

Via Investor's Business Daily

< Previous 1 2

...

21 22 23 24 25 26 27 28 29

...

99 100 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Merck & Co (NY:MRK)

Headline News about Merck & Co

Starting at $3.75/week.

Subscribe Today